Obesity and dyslipidemia: a review of current evidence
J Vekic, A Stefanovic, A Zeljkovic - Current Obesity Reports, 2023 - Springer
Abstract Purpose of Review Obesity is accompanied by atherogenic dyslipidemia, a specific
lipid disorder characterized by both quantitative and qualitative changes of plasma …
lipid disorder characterized by both quantitative and qualitative changes of plasma …
Lifestyle interventions for the treatment of women with gestational diabetes
Background Gestational diabetes (GDM) is glucose intolerance, first recognised in
pregnancy and usually resolving after birth. GDM is associated with both short‐and long …
pregnancy and usually resolving after birth. GDM is associated with both short‐and long …
Plasma concentrations of lipids during pregnancy and the risk of gestational diabetes mellitus: A longitudinal study: 妊娠期间的血脂浓度与妊娠糖尿病风险: 一项纵向 …
摘要背景目前已经有研究证实血脂异常与妊娠糖尿病(gestational diabetes mellitus, GDM)
相关, 但是很少有研究对整个妊娠期间的血脂进行纵向测量. 当前这项研究的目的是描述整个 …
相关, 但是很少有研究对整个妊娠期间的血脂进行纵向测量. 当前这项研究的目的是描述整个 …
Metabolic syndrome in pregnancy and risk for adverse pregnancy outcomes: A prospective cohort of nulliparous women
Background Obesity increases the risk for developing gestational diabetes mellitus (GDM)
and preeclampsia (PE), which both associate with increased risk for type 2 diabetes mellitus …
and preeclampsia (PE), which both associate with increased risk for type 2 diabetes mellitus …
Maternal β-cell adaptations in pregnancy and placental signalling: implications for gestational diabetes
BL Moyce, VW Dolinsky - International journal of molecular sciences, 2018 - mdpi.com
Rates of gestational diabetes mellitus (GDM) are on the rise worldwide, and the number of
pregnancies impacted by GDM and resulting complications are also increasing. Pregnancy …
pregnancies impacted by GDM and resulting complications are also increasing. Pregnancy …
Maternal lipids and fetal overgrowth: making fat from fat
LA Barbour, TL Hernandez - Clinical therapeutics, 2018 - Elsevier
There is increasing recognition that maternal glucose concentrations lower than those
previously used for diagnosis of gestational diabetes mellitus (GDM) and targeted for …
previously used for diagnosis of gestational diabetes mellitus (GDM) and targeted for …
Developmental programming of obesity and diabetes in mouse, monkey, and man in 2018: where are we headed?
JE Friedman - Diabetes, 2018 - Am Diabetes Assoc
Childhood obesity and its comorbidities continue to accelerate across the globe. Two-thirds
of pregnant women are obese/overweight, as are 20% of preschoolers. Gestational diabetes …
of pregnant women are obese/overweight, as are 20% of preschoolers. Gestational diabetes …
National lipid association annual summary of clinical lipidology 2016
HE Bays, PH Jones, CE Orringer, WV Brown… - Journal of clinical …, 2016 - Elsevier
Abstract The National Lipid Association (NLA) Annual Summary of Clinical Lipidology is a
yearly updated summary of principles important to the patient-centered evaluation …
yearly updated summary of principles important to the patient-centered evaluation …
A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes
LA Barbour, C Scifres, AM Valent, JE Friedman… - American journal of …, 2018 - Elsevier
Use of oral agents to treat gestational diabetes mellitus remains controversial. Recent
recommendations from the Society for Maternal-Fetal Medicine assert that metformin may be …
recommendations from the Society for Maternal-Fetal Medicine assert that metformin may be …
Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta‐analysis
Background Low and high birthweight is known to increase the risk of acute and longer‐term
adverse outcomes, such as stillbirth, infant mortality, obesity, type 2 diabetes and …
adverse outcomes, such as stillbirth, infant mortality, obesity, type 2 diabetes and …